Raras
Buscar doenças, sintomas, genes...
Síndrome Wiedemann-Steiner
ORPHA:319182CID-10 · Q87.1OMIM 605130DOENÇA RARA

A síndrome de Wiedemann-Steiner é uma condição genética rara caracterizada por características faciais distintas, cotovelos peludos, baixa estatura e deficiência intelectual. Esta condição é causada por alterações (mutações) no gene KMT2A (também conhecido como gene MLL). É herdado de maneira autossômica dominante. A maioria dos casos resulta de novas mutações (de novo) que ocorrem apenas em um óvulo ou espermatozóide, ou logo após a concepção. O tratamento é sintomático e de suporte e pode incluir aulas de educação especial e terapias fonoaudiológicas e ocupacionais destinadas a aumentar o funcionamento motor e a linguagem.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Wiedemann-Steiner é uma condição genética rara caracterizada por características faciais distintas, cotovelos peludos, baixa estatura e deficiência intelectual. Esta condição é causada por alterações (mutações) no gene KMT2A (também conhecido como gene MLL). É herdado de maneira autossômica dominante. A maioria dos casos resulta de novas mutações (de novo) que ocorrem apenas em um óvulo ou espermatozóide, ou logo após a concepção. O tratamento é sintomático e de suporte e pode incluir aulas de educação especial e terapias fonoaudiológicas e ocupacionais destinadas a aumentar o funcionamento motor e a linguagem.

Pesquisas ativas
1 ensaio
1 total registrados no ClinicalTrials.gov
Publicações científicas
102 artigos
Último publicado: 2026 Apr 11

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
84
pacientes catalogados
Início
Childhood
+ infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
17 sintomas
🦴
Ossos e articulações
16 sintomas
🧠
Neurológico
10 sintomas
👁️
Olhos
8 sintomas
📏
Crescimento
6 sintomas
🫃
Digestivo
4 sintomas

+ 36 sintomas em outras categorias

Características mais comuns

100%prev.
Início na infância
Obrigatório (100%)
100%prev.
Coxim digital proeminente
Frequência: 3/3
100%prev.
Hipertricose generalizada
Obrigatório (100%)
100%prev.
Nariz bulboso
Obrigatório (100%)
100%prev.
Atraso global do desenvolvimento
Frequência: 11/11
100%prev.
Pé plano
Obrigatório (100%)
104sintomas
Muito frequente (20)
Frequente (43)
Ocasional (33)
Muito raro (1)
Sem dados (7)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 104 características clínicas mais associadas, ordenadas por frequência.

Início na infânciaChildhood onset
Obrigatório (100%)100%
Coxim digital proeminenteProminent digit pad
Frequência: 3/3100%
Hipertricose generalizadaGeneralized hypertrichosis
Obrigatório (100%)100%
Nariz bulbosoBulbous nose
Obrigatório (100%)100%
Atraso global do desenvolvimentoGlobal developmental delay
Frequência: 11/11100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico102PubMed
Últimos 10 anos99publicações
Pico202216 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

KMT2AHistone-lysine N-methyltransferase 2ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Histone methyltransferase that plays an essential role in early development and hematopoiesis (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:2

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genesRUNX1 regulates transcription of genes involved in differentiation of HSCsPhosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promotersThe CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complexTranscriptional regulation of granulopoiesis
MECANISMO DE DOENÇA

Wiedemann-Steiner syndrome

A syndrome characterized by hairy elbows (hypertrichosis cubiti), intellectual disability, a distinctive facial appearance, and short stature. Facial characteristics include long eyelashes, thick or arched eyebrows with a lateral flare, and downslanting and vertically narrow palpebral fissures.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
34.8 TPM
Cérebro - Hemisfério cerebelar
32.5 TPM
Ovário
26.9 TPM
Artéria tibial
25.5 TPM
Útero
24.7 TPM
OUTRAS DOENÇAS (7)
Wiedemann-Steiner syndromemixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)mixed phenotype acute leukemia with t(v;11q23.3)B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
HGNC:7132UniProt:Q03164

Variantes genéticas (ClinVar)

839 variantes patogênicas registradas no ClinVar.

🧬 KMT2A: NM_001197104.2(KMT2A):c.4646G>A (p.Trp1549Ter) ()
🧬 KMT2A: NM_001197104.2(KMT2A):c.11884T>C (p.Cys3962Arg) ()
🧬 KMT2A: NM_001197104.2(KMT2A):c.38C>A (p.Pro13His) ()
🧬 KMT2A: NM_001197104.2(KMT2A):c.11081del (p.Lys3694fs) ()
🧬 KMT2A: NM_001197104.2(KMT2A):c.5016del (p.Pro1673fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 416 variantes classificadas pelo ClinVar.

291
83
42
Patogênica (70.0%)
VUS (20.0%)
Benigna (10.1%)
VARIANTES MAIS SIGNIFICATIVAS
KMT2A: NM_001197104.2(KMT2A):c.11884T>C (p.Cys3962Arg) [Likely pathogenic]
KMT2A: NM_001197104.2(KMT2A):c.11081del (p.Lys3694fs) [Pathogenic]
KMT2A: NM_001197104.2(KMT2A):c.7784del (p.Pro2595fs) [Pathogenic]
KMT2A: NM_001197104.2(KMT2A):c.3461G>T (p.Arg1154Leu) [Likely pathogenic]
KMT2A: NM_001197104.2(KMT2A):c.6175T>G (p.Trp2059Gly) [Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Wiedemann-Steiner

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
98 papers (10 anos)
#1

Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.

Clinical genetics2026 Apr

O'Donnell-Luria-Rodan syndrome (ODLURO) is a rare disorder caused by a pathogenic variant in KMT2E and associated with intellectual disability. To date, the neurobehavioral phenotype of this disorder remains elusive. Here, we aimed to characterize the cognitive and behavioral profiles associated with ODLURO and compare the trends with those of other disorders associated with epigenetic regulation of gene expression at H3K4, Wiedemann-Steiner syndrome (WDSTS) and Kabuki syndrome type 1 (KABUK1). Findings show prominent behavioral features in ODLURO include problems with anxiety (33%), attention (67%), and executive function (50%) (working memory, cognitive inflexibility), with similar severity ratings as WDSTS and KABUK1. Two-thirds of participants were rated in the moderate-to-severe range in overall autism-like behaviors on the SRS-2; however, study findings highlighted a pattern of most day-to-day difficulties in Restricted/Repetitive Behaviors paired with relatively fewer challenges in Social Motivation, comparable to trends reported in WDSTS. Sleep disturbances are common in ODLURO (85%) and associated with behavior regulation difficulties, highlighting the importance of early screening/intervention. In brief, ODLURO shares similarities in neurobehavioral functioning with other disorders of H3K4 modulation of gene expression, warranting further systematic research with cross-syndrome comparisons to elucidate the relationship between epigenetic regulation and pathogenesis of neurodevelopmental disorders.

#2

Heterozygous frameshift KMT2A variant in a patient with Wiedemann-Steiner syndrome.

Human genome variation2026 Mar 17

Here we report a case of a Japanese girl with Wiedemann-Steiner syndrome carrying a novel heterozygous frameshift variant of KMT2A (NM_001197104.2:c.10123del, p.Thr3375ProfsTer7). Her clinical features included severe pre- and postnatal growth failure, global developmental delay, hypertrichosis and complete agenesis of the corpus callosum. The identified variant truncates the protein, abolishes the C-terminal SET domain required for histone methyltransferase activity, and is predicted to trigger nonsense-mediated mRNA decay, resulting in KMT2A haploinsufficiency-the primary pathogenic mechanism of Wiedemann-Steiner syndrome. This report documents a previously unreported loss-of-function variant in KMT2A with detailed molecular interpretation and phenotypic characterization, contributing to refinement of the mutational spectrum associated with Wiedemann-Steiner syndrome.

#3

Neuronal Heterotopy in a Patient with Wiedemann-Steiner Syndrome Caused by a Truncating KMT2A Variant: Clinical and Genetic Correlations.

Reports (MDPI)2026 Jan 26

Background and clinical significance: Wiedemann-Steiner syndrome (WSS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous pathogenic variants in the KMT2A gene, which encodes a histone lysine methyltransferase essential for chromatin regulation. Affected individuals commonly present with developmental delay, intellectual disability, behavioral disturbances, short stature, characteristic facial features, and hypertrichosis, along with variable additional congenital anomalies. Emerging genotype-phenotype correlations suggest two functional classes of KMT2A variants: loss-of-function variants, typically associated with the classic WSS phenotype and muscular hypotonia, and non-loss-of-function variants, which more often correlate with drug-resistant epilepsy and microcephaly. No recurrent variants or clear genotype-phenotype correlations have been established outside the CXXC domain, and most pathogenic variants are private or novel, contributing to phenotypic heterogeneity. Case presentation: We present a case of a 14-year-old female with a pathogenic nonsense truncating variant in the KMT2A gene and typical features of Wiedemann-Steiner syndrome. Additionally, the patient exhibited microcephaly and structural epilepsy due to neuronal heterotopy-features that are rarely described in individuals with truncating variants in this gene and have not been reported in the two published cases of individuals with the same mutation. Conclusions: This case highlights atypical genotype-phenotype correlations and expands the clinical spectrum of truncating KMT2A variants in Wiedemann-Steiner syndrome.

#4

Successful ECT in a Patient With Wiedemann-Steiner Syndrome and Insights From Twin-Based EEG Analysis.

The journal of ECT2026 Jan 20

We describe a young man with Wiedemann-Steiner syndrome (WSS) suffering from severe depression with psychotic and catatonic features, who showed a marked and lasting response to electroconvulsive therapy (ECT). Resting-state electroencephalogram (EEG) was recorded before and after the ECT course in the patient, and-at comparable time points-in his monozygotic twin brother. This offered unique neurophysiological insights into candidate mechanisms underlying ECT's therapeutic effects. After 16 ECT sessions, the patient completely remitted. Pretreatment EEG of the patient showed a lower amplitude, less fluctuating and more symmetrical posterior dominant rhythm, which partly normalized after the successful ECT course. Quantitative EEG analyses using a computational corticothalamic model suggested that thalamic intrinsic responsiveness in the recovered patient decreased, normalizing toward his twin brother's values after the ECT course. These findings may point to normalization of thalamic inhibitory function as a candidate mechanism of the therapeutic effect of ECT in treating catatonic psychotic depression.

#5

Revisiting Wiedemann-Steiner Syndrome: Novel KMT2A Variants and Broadened Clinical Spectrum.

Balkan medical journal2026 Feb 02

Wiedemann-Steiner syndrome (WDSTS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous pathogenic variants in KMT2A. Although several large international cohorts have helped define its broad clinical spectrum, data from underrepresented populations remain limited. To characterize the molecular and phenotypic spectrum of Turkish patients with WDSTS and compare these findings with previously published cohorts. Multicenter retrospective cohort study. Sixteen individuals from 15 unrelated families were recruited across Türkiye. Clinical information was obtained through medical records and systematic phenotyping. Molecular analyses included next-generation sequencing or targeted variant testing, and the variants were classified according to the American College of Medical Genetics and Genomics guidelines. Fifteen distinct KMT2A variants were identified, including nine novel alleles. Most variants were predicted to result in loss of function; only one was a missense substitution. Neurodevelopmental involvement was prominent, with developmental and speech delays, intellectual disability, and behavioral comorbidities such as autism spectrum disorder and attention-deficit/hyperactivity disorder. Endocrine evaluation revealed growth hormone deficiency in approximately half of the tested patients. Ophthalmologic, cardiac, and dental abnormalities, including delayed tooth eruption, further expanded the known phenotype. Additional systemic features included skeletal, genitourinary, and immunological findings. Comparison with previously reported cohorts displayed no statistically significant genotype-phenotype correlations, although truncating variants appeared to be associated with more pronounced neurodevelopmental and behavioral manifestations. This report presents the largest Turkish WDSTS cohort to date, expands the known KMT2A variant spectrum with nine novel alleles, and highlights several underreported clinical features. Beyond its immediate clinical relevance, the study further supports KMT2A as a key chromatin regulator and an "umbrella gene" within the chromatinopathy spectrum. Growing recognition of these disorders underscores the need for systematic, multidisciplinary surveillance and contributes to the expanding global understanding of their shared pathogenic mechanisms.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC80 artigos no totalmostrando 99

2026

Heterozygous frameshift KMT2A variant in a patient with Wiedemann-Steiner syndrome.

Human genome variation
2026

Neuronal Heterotopy in a Patient with Wiedemann-Steiner Syndrome Caused by a Truncating KMT2A Variant: Clinical and Genetic Correlations.

Reports (MDPI)
2026

Successful ECT in a Patient With Wiedemann-Steiner Syndrome and Insights From Twin-Based EEG Analysis.

The journal of ECT
2026

Digital Transformation and the Reconstruction of Nursing Professional Identity: Moving Beyond the Intangible Professional Project.

Journal of advanced nursing
2026

Revisiting Wiedemann-Steiner Syndrome: Novel KMT2A Variants and Broadened Clinical Spectrum.

Balkan medical journal
2026

Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.

Clinical genetics
2025

Wiedemann-Steiner syndrome: description of genetic profiles and clinical phenotypes of 10 Korean pediatric patients.

BMC medical genomics
2025

In utero rescue of neurological dysfunction in a mouse model of Wiedemann-Steiner syndrome.

JCI insight
2025

Academic Learning Profiles Across Disorders of KMT2 Gene Family: Superimposed and Distinct Features Across Kabuki, Wiedemann-Steiner and ODLURO Syndromes.

Journal of intellectual disability research : JIDR
2025

Clinical and molecular results in 15 Turkish patients with Wiedemann-Steiner syndrome: identification of eight novel KMT2A variants and a case of dual molecular diagnosis in the CSNK2A1.

European journal of pediatrics
2025

Delineating the Cognitive Profile of ODLURO Syndrome: Emergent Clues on the Endophenotype Across KMT2 Disorders.

American journal of medical genetics. Part A
2025

Diagnosis and recombinant human growth hormone treatment of Wiedemann-Steiner syndrome: discovery of novel KMT2A variants and review of existing literature.

BMC pediatrics
2025

Clinical Characteristics of KMT2A Gene-Related Wiedemann-Steiner Syndrome and Progress in Recombinant Human Growth Hormone Therapy for Short-Stature Children.

Clinical endocrinology
2025

Behavioral profiles and social relationships in Wiedemann-Steiner syndrome: parent reports on 25 cases.

Orphanet journal of rare diseases
2025

KMT2A-CBL fusion gene in the first reported case of T-cell acute lymphoblastic leukemia associated with Wiedemann-Steiner syndrome.

International journal of hematology
2025

Variants in Chromatin Remodeling Genes Are Involved in Patients With Chiari Malformation Type 1.

Birth defects research
2025

A case of Wiedemann-Steiner syndrome caused by a novel KMT2A c.8862del variant.

Pediatrics international : official journal of the Japan Pediatric Society
2024

MLL/WDR5 complex recruits centriolar satellite protein Cep72 to regulate microtubule nucleation and spindle formation.

Science advances
2025

Quantifying neurobehavioral profiles across neurodevelopmental genetic syndromes and idiopathic neurodevelopmental disorders.

Developmental medicine and child neurology
2024

Sleep correlates of behavior functioning in Cornelia de Lange syndrome.

American journal of medical genetics. Part A
2024

Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann-Steiner Syndrome.

Genes
2024

Trio-based whole exome sequencing in patients with ectopic posterior pituitary.

Frontiers in pediatrics
2024

Aberrant splicing caused by a novel KMT2A variant in Wiedemann-Steiner syndrome.

Molecular genetics &amp; genomic medicine
2024

Atlantoaxial facet fixation using cervical facet cage: technical case report and review of the literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Variants in KMT2A in Three Individuals with Previous Suspicion of 22q11.2 Deletion Syndrome.

Genes
2023

Clinical application of whole exome sequencing technology in small-for-gestational-age children.

American journal of translational research
2023

Diagnostic approach to a paediatric patient with Wiedemann-Steiner syndrome with de novo missense variant in the KMT2A gene - a case report.

Annals of agricultural and environmental medicine : AAEM
2023

A de novo mutation of ADAMTS8 in a patient with Wiedemann-Steiner syndrome.

Molecular cytogenetics
2024

Associations Between Executive Functioning, Behavioral Functioning, and Adaptive Functioning Difficulties in Wiedemann-Steiner Syndrome.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
2023

The social phenotype associated with Wiedemann-Steiner syndrome: Autistic traits juxtaposed with high social drive and prosociality.

American journal of medical genetics. Part A
2023

Pathogenic Presentation of a Variant of Uncertain Significance in a Puerto Rican Patient With Wiedemann-Steiner Syndrome.

Cureus
2023

The epileptology of Wiedemann-Steiner syndrome: Electroclinical findings in five patients with KMT2A pathogenic variants.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

[A case of Wiedemann-Steiner syndrome characterized by amenorrhoea, hypertrichosis, short stature, intellectual disability].

Zhonghua nei ke za zhi
2023

Novel variants and phenotypic heterogeneity in a cohort of 11 Chinese children with Wiedemann-Steiner syndrome.

Frontiers in genetics
2022

Evaluation of immunological abnormalities in patients with rare syndromes.

Central-European journal of immunology
2024

Elemental Milk Formula as a Possible Cause of Hypophosphatemic Rickets in Wiedemann-Steiner Syndrome.

Journal of clinical research in pediatric endocrinology
2023

[Clinical features and genetic analysis of a case of Wiedemann-Steiner syndrome due to variant of KMT2A gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Unique profile of academic learning difficulties in Wiedemann-Steiner syndrome.

Journal of intellectual disability research : JIDR
2023

Anxiety in Wiedemann-Steiner syndrome.

American journal of medical genetics. Part A
2022

Sleep disturbances correlate with behavioral problems among individuals with Wiedemann-Steiner syndrome.

Frontiers in genetics
2022

Wiedemann-Steiner Syndrome: Case Report and Review of Literature.

Children (Basel, Switzerland)
2022

Case report: 11-ketotestosterone may potentiate advanced bone age as seen in some cases of Wiedemann-Steiner Syndrome.

Frontiers in endocrinology
2023

Individuals with Wiedemann-Steiner syndrome show nonverbal reasoning and visuospatial defects with relative verbal skill sparing.

Journal of the International Neuropsychological Society : JINS
2022

Phenotypic Variation in Two Siblings Affected with Shwachman-Diamond Syndrome: The Use of Expert Variant Interpreter (eVai) Suggests Clinical Relevance of a Variant in the KMT2A Gene.

Genes
2022

Neurocognitive and neurobehavioral characterization of two frequent forms of neurodevelopmental disorders: the DYRK1A and the Wiedemann-Steiner syndromes.

Clinical genetics
2023

Growth hormone deficiency in a boy with Wiedemann-Steiner syndrome: a case report and review.

Annals of pediatric endocrinology &amp; metabolism
2022

[Identification of a novel frameshift variant in the KMT2A gene of a child with Wiedemann-Steiner syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Feeding disorder in a patient with Wiedemann-Steiner syndrome.

Pediatrics international : official journal of the Japan Pediatric Society
2022

Missense variants causing Wiedemann-Steiner syndrome preferentially occur in the KMT2A-CXXC domain and are accurately classified using AlphaFold2.

PLoS genetics
2022

Premature Loss of Deciduous Teeth as a Symptom of Systemic Disease: A Narrative Literature Review.

International journal of environmental research and public health
2022

KMT2A: Umbrella Gene for Multiple Diseases.

Genes
2022

Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome.

International journal of molecular sciences
2022

[Analysis of gene variation and clinical characteristics of Wiedemann-Steiner syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2022

Severe Hip Dysplasia in Wiedemann-Steiner Syndrome Treated with Bilateral Bernese Periacetabular Osteotomy: A Case Report.

JBJS case connector
2021

Wiedemann-Steiner Syndrome with a Pathogenic Variant in KMT2A from Taiwan.

Children (Basel, Switzerland)
2022

Corrigendum Re: Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome. Am J Med Genet A. 2021;185A(6):1649-1665. Doi:10.1002/ajmg.a.62124".

American journal of medical genetics. Part A
2021

Phenotype, genotype and long-term prognosis of 40 Chinese patients with isobutyryl-CoA dehydrogenase deficiency and a review of variant spectra in ACAD8.

Orphanet journal of rare diseases
2021

Three de novo variants in KMT2A (MLL) identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome.

Molecular genetics &amp; genomic medicine
2021

[A case of Wiedemann-Steiner syndrome caused by a novel variation of the KMT2A gene].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2021

Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome.

American journal of medical genetics. Part A
2021

Wiedemann-Steiner Syndrome as a Differential Diagnosis of Cornelia de Lange Syndrome Using Targeted Next-Generation Sequencing: A Case Report.

Molecular syndromology
2021

Wiedemann-Steiner syndrome: A case report.

Clinical case reports
2021

[Wiedemann-Steiner syndrome due to novel nonsense variant of KMT2A gene in a case].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

Broad neurodevelopmental features and cortical anomalies associated with a novel de novo KMT2A variant in Wiedemann-Steiner syndrome.

European journal of medical genetics
2021

Trio-WES reveals a novel de novo missense mutation of KMT2A in a Chinese patient with Wiedemann-Steiner syndrome: A case report.

Molecular genetics &amp; genomic medicine
2020

Corrigendum to "Preaxial polydactyly in an individual with Wiedemann-Steiner syndrome caused by a novel nonsense mutation in KMT2A. Am J Med Genet Part A. 2017;173A:2821-2,825".

American journal of medical genetics. Part A
2020

Expanding the phenotype of Wiedemann-Steiner syndrome: Craniovertebral junction anomalies.

American journal of medical genetics. Part A
2022

Wiedemann-Steiner Syndrome: A Rare Differential Diagnosis of Neurodevelopmental Delay and Dysmorphic Features.

Journal of pediatric genetics
2021

Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes.

European journal of human genetics : EJHG
2020

Physical Therapy Management of Wiedemann-Steiner Syndrome From Birth to 3 Years.

Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association
2020

Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation.

Communications biology
2020

The phenotype-driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes.

Molecular genetics &amp; genomic medicine
2020

Wiedemann-steiner syndrome with a de novo mutation in KMT2A: A case report.

Medicine
2020

Triple diagnosis of Wiedemann-Steiner, Waardenburg and DLG3-related intellectual disability association found by WES: A case report.

The journal of gene medicine
2020

Expanding the phenotypic and genotypic spectrum of Wiedemann-Steiner syndrome: First patient from India.

American journal of medical genetics. Part A
2020

Wiedemann-Steiner syndrome in two patients from Portugal.

American journal of medical genetics. Part A
2019

A novel de novo mutation (p.Pro1310Glnfs*46) in KMT2A caused Wiedemann-Steiner Syndrome in a Chinese boy with postnatal growth retardation: a case report.

Molecular biology reports
2019

Wiedemann-Steiner syndrome with a novel pathogenic variant in KMT2A: a case report.

Colombia medica (Cali, Colombia)
2019

Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variants.

NPJ genomic medicine
2019

A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.

BMC medical genetics
2019

The progression of Wiedemann-Steiner syndrome in adulthood and two novel variants in the KMT2A gene.

American journal of medical genetics. Part A
2018

[Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay].

Zhonghua yi xue za zhi
2018

Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients.

Orphanet journal of rare diseases
2018

Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner Syndrome.

Endocrinology, diabetes &amp; metabolism case reports
2018

RNA Sequencing and Pathway Analysis Identify Important Pathways Involved in Hypertrichosis and Intellectual Disability in Patients with Wiedemann-Steiner Syndrome.

Neuromolecular medicine
2018

TASP1 is deleted in an infant with developmental delay, microcephaly, distinctive facial features, and multiple congenital anomalies.

Clinical genetics
2018

Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: A study of 33 French cases.

Clinical genetics
2018

Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome.

European journal of human genetics : EJHG
2017

Preaxial polydactyly in an individual with Wiedemann-Steiner syndrome caused by a novel nonsense mutation in KMT2A.

American journal of medical genetics. Part A
2017

Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman-Steiner and Roifman syndromes.

Scientific reports
2017

Wiedemann-Steiner syndrome: Novel pathogenic variant and review of literature.

European journal of medical genetics
2017

Wiedemann-Steiner Syndrome With 2 Novel KMT2A Mutations.

Journal of child neurology
2017

Further delineation of the phenotype of truncating KMT2A mutations: The extended Wiedemann-Steiner syndrome.

American journal of medical genetics. Part A
2016

Congenital immunodeficiency in an individual with Wiedemann-Steiner syndrome due to a novel missense mutation in KMT2A.

American journal of medical genetics. Part A
2015

Whole exome sequencing reveals a MLL de novo mutation associated with mild developmental delay and without 'hairy elbows': expanding the phenotype of Wiedemann-Steiner syndrome.

Journal of genetics
2015

A Case of Wiedemann-Steiner Syndrome Associated with a 46,XY Disorder of Sexual Development and Gonadal Dysgenesis.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2015

A de novo Mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome.

American journal of medical genetics. Part A
2016

Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations.

Clinical genetics
2015

Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes.

The Journal of clinical investigation

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Wiedemann-Steiner.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Wiedemann-Steiner

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.
    Clinical genetics· 2026· PMID 41137515mais citado
  2. Heterozygous frameshift KMT2A variant in a patient with Wiedemann-Steiner syndrome.
    Human genome variation· 2026· PMID 41844570mais citado
  3. Neuronal Heterotopy in a Patient with Wiedemann-Steiner Syndrome Caused by a Truncating KMT2A Variant: Clinical and Genetic Correlations.
    Reports (MDPI)· 2026· PMID 41718288mais citado
  4. Successful ECT in a Patient With Wiedemann-Steiner Syndrome and Insights From Twin-Based EEG Analysis.
    The journal of ECT· 2026· PMID 41557619mais citado
  5. Revisiting Wiedemann-Steiner Syndrome: Novel KMT2A Variants and Broadened Clinical Spectrum.
    Balkan medical journal· 2026· PMID 41320952mais citado
  6. Hyperprolactinemia, hyperandrogenemia, pituitary adenoma, and metabolic disorders in Wiedemann-Steiner syndrome: a case report.
    BMC Endocr Disord· 2026· PMID 41965552recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:319182(Orphanet)
  2. OMIM OMIM:605130(OMIM)
  3. MONDO:0011518(MONDO)
  4. GARD:5565(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q24975353(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Wiedemann-Steiner
Compêndio · Raras BR

Síndrome Wiedemann-Steiner

ORPHA:319182 · MONDO:0011518
Prevalência
<1 / 1 000 000
Casos
84 casos conhecidos
Herança
Autosomal dominant
CID-10
Q87.1 · Síndromes com malformações congênitas associadas predominantemente com nanismo
Ensaios
1 ativos
Início
Childhood, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1854630
Repurposing
19 candidatos
azosemideelectrolyte reabsorption inhibitor
benzthiazidecarbonic anhydrase inhibitor
bumetanidesolute carrier family member inhibitor
+16 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades